X4 Pharmaceuticals (XFOR) Net Margin (2018 - 2025)
Historic Net Margin for X4 Pharmaceuticals (XFOR) over the last 6 years, with Q3 2025 value amounting to 1689.24%.
- X4 Pharmaceuticals' Net Margin rose 48636200.0% to 1689.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 279.51%, marking a year-over-year increase of 12128300.0%. This contributed to the annual value of 1442.31% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, X4 Pharmaceuticals' Net Margin is 1689.24%, which was up 48636200.0% from 1304.66% recorded in Q2 2025.
- Over the past 5 years, X4 Pharmaceuticals' Net Margin peaked at 16133.75% during Q2 2024, and registered a low of 6552.86% during Q3 2024.
- In the last 4 years, X4 Pharmaceuticals' Net Margin had a median value of 2148.62% in 2022 and averaged 1428.58%.
- Data for X4 Pharmaceuticals' Net Margin shows a peak YoY increase of 48636200bps (in 2025) and a maximum YoY decrease of -174384100bps (in 2025) over the last 5 years.
- Quarter analysis of 4 years shows X4 Pharmaceuticals' Net Margin stood at 2544.06% in 2022, then decreased by -15bps to 2165.92% in 2023, then plummeted by -224bps to 2696.07% in 2024, then soared by 37bps to 1689.24% in 2025.
- Its last three reported values are 1689.24% in Q3 2025, 1304.66% for Q2 2025, and 0.98% during Q1 2025.